Detalhe da pesquisa
1.
Effects of Renal Function on Crizotinib Pharmacokinetics: Dose Recommendations for Patients with ALK-Positive Non-Small Cell Lung Cancer.
Clin Drug Investig
; 37(4): 363-373, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28035616
2.
Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Thorac Oncol
; 12(1): 145-151, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27697581
3.
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.
Blood
; 105(3): 986-93, 2005 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15459012
4.
A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia.
Blood
; 102(8): 2763-7, 2003 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12843001